583 related articles for article (PubMed ID: 15776319)
1. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
2. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
Bosch MM; Boltshauser E; Harpes P; Landau K
Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
[TBL] [Abstract][Full Text] [Related]
4. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
6. Management strategies in neurofibromatosis type 2.
Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
9. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
[TBL] [Abstract][Full Text] [Related]
10. Outcome from surgery for vestibular schwannomas in children.
MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
[TBL] [Abstract][Full Text] [Related]
11. [Neurofibromatosis type 2 and auditory brainstem implantation].
Elvsåshagen T; Solyga V; Bakke SJ; Heiberg A; Kerty E
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1469-73. PubMed ID: 19690597
[TBL] [Abstract][Full Text] [Related]
12. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
13. Skin abnormalities in neurofibromatosis 2.
Mautner VF; Lindenau M; Baser ME; Kluwe L; Gottschalk J
Arch Dermatol; 1997 Dec; 133(12):1539-43. PubMed ID: 9420538
[TBL] [Abstract][Full Text] [Related]
14. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
15. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
[TBL] [Abstract][Full Text] [Related]
17. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
18. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
[TBL] [Abstract][Full Text] [Related]
20. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
